NEW YORK (GenomeWeb News) – Laboratory Corporation of America is offering Roche's new Cobas AmpliPrep/Cobas TaqMan HCV test, which the US Food and Drug Administration cleared for marketing in October 2008.
The test is fully automated and uses Roche's proprietary real-time PCR technology to quantify the amount of virus in an individual's blood. Physicians can use it to monitor viral load at baseline and during treatment to help determine the effectiveness of therapy.
LabCorp is the first national clinical lab to offer HCV PCR testing using the new assay, the Burlington, NC-based clinical lab firm said yesterday.
LabCorp already offers Roche's AmpliPrep/COBAS TaqMan HIV-1 test under an agreement signed in May 2007.